Дэйв Эспри - Биохакинг мозга

Sultan Ayoub Meo et al., “Association of Exposure to Radio-Frequency Electromagnetic Field Radiation (RF-EMFR) Generated by Mobile Phone Base Stations with Glycated Hemoglobin (HbA1c) and Risk of Type 2 Diabetes Mellitus,” International Journal of Environmental Research and Public Health 12, no. 11 (November 2015): 14519–14528, DOI: 10.3390/ijerph121114519.

Howard H. Carter et al., “Cardiovascular Responses to Water Immersion in Humans: Impact on Cerebral Perfusion,” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 306, no. 9 (May 2014): R636–640, DOI: 10.1152/ajpregu.00516.2013.

Бреус, Майкл. Всегда вовремя. Узнайте свой хронотип и живите в согласии со своим биоритмом.М.: Манн, Иванов и Фербер, 2017. Прим. ред.

Howard H. Carter et al., “Cardiovascular Responses to Water Immersion in Humans: Impact on Cerebral Perfusion,” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 306, no. 9 (May 2014): R636–640, DOI: 10.1152/ajpregu.00516.2013.

Gabriel S. Chiu et al., “Hypoxia/Reoxygenation Impairs Memory Formation via Adenosine-Dependent Activation of Caspase 1,” Journal of Neuroscience: The Official Journal of the Society for Neuroscience 32, no. 40 (October 3, 2012): 13945–13955, DOI: 10.1523/JNEUROSCI.0704-12.2012.

R. C. Loopstra-Masters et al., “Associations between the Intake of Caffeinated and Decaffeinated Coffee and Measures of Insulin Sensitivity and Beta Cell Function,” Diabetologia 54, no. 2 (February 2011): 320–328, DOI: 10.1007/s00125-010-1957-8.

Salome A. Rebello et al., “Coffee and Tea Consumption in Relation to Inflammation and Basal Glucose Metabolism in a Multi-Ethnic Asian Population: A Cross-Sectional Study,” Nutrition Journal 10 (June 2, 2011): 61, DOI: 10.1186/1475-2891-10-61.

Andrew M. James et al., “Interactions of Mitochondria-Targeted and Untargeted Ubiquinones with the Mitochondrial Respiratory Chain and Reactive Oxygen Species,” Journal of Biological Chemistry 280, no. 22 (June 3, 2005): 21295–312, DOI: 10.1074/jbc.M501527200.

Dana E. King et al., “Dietary Magnesium and C-Reactive Protein Levels,” Journal of the American College of Nutrition 24, no. 3 (June 2005): 166–171.

Kevin A. Feeney et al., “Daily Magnesium Fluxes Regulate Cellular Timekeeping and Energy Balance,” Nature 532, no. 7599 (April 21, 2016): 375–379, DOI: 10.1038/nature17407.

Sean R. Hosein, “Can Vitamin D Increase Testosterone Concentrations in Men?” CATIE — Canada’s Source for HIV and Hepatitis C Information, September 2011, http://www.catie.ca/en/treatmentupdate/treatmentupdate-185/nutrition/can-vitamin-increase-testosterone-concentrations-men.

Pietro Ameri et al., “Interactions between Vitamin D and IGF-I: From Physiology to Clinical Practice,” Clinical Endocrinology 79, no. 4 (October 2013): 457–63, DOI: 10.1111/cen.12268.

Akash Sinha, “Shining Some Light on the Powerhouse of the Cell — Is There a Link between Vitamin D and Mitochondrial Function in Humans?” (Conference abstract, Canadian Pediatric Endocrine Group Annual Meeting, Montréal, QC, February 22, 2014).

Caroline Rae et al., “Oral Creatine Monohydrate Supplementation Improves Brain Performance: A Double-Blind, Placebo-Controlled, Crossover Trial.,” Proceedings of the Royal Society B: Biological Sciences 270, no. 1529 (October 22, 2003): 2147–2150, DOI: 10.1098/rspb.2003.2492.

Alexander M. Wolf et al., “Astaxanthin Protects Mitochondrial Redox State and Functional Integrity against Oxidative Stress,” Journal of Nutritional Biochemistry 21, no. 5 (May 2010): 381–389, DOI: 10.1016/j.jnutbio.2009.01.011.

U. Justesen, P. Knuthsen, and T. Leth, “Determination of Plant Polyphenols in Danish Foodstuffs by HPLC-UV and LC-MS Detection,” Cancer Letters 114, no. 1–2 (March 19, 1997): 165–167.

http://umm.edu/health/medical/altmed/herb/green-tea.

D. O. Kim et al., “Sweet and Sour Cherry Phenolics and Their Protective Effects on Neuronal Cells,” Journal of Agricultural and Food Chemistry 53 (2005): 9921–9927.

Tiffany Greco and Gary Fiskum, “Brain Mitochondria from Rats Treated with Sulforaphane Are Resistant to Redox-Regulated Permeability Transition,” Journal of Bioenergetics and Biomembranes 42, no. 6 (December 2010): 491–497, DOI: 10.1007/s10863-010-9312-9.

J. M. Haslam and H. A. Krebs, “The Permeability of Mitochondria to Oxaloacetate and Malate,” Biochemical Journal 107, no. 5 (May 1968): 659–667; B. S. Meldrum, “Glutamate as a Neurotransmitter in the Brain: Review of Physiology and Pathology,” Journal of Nutrition 130, no. 4S Suppl. (April 2000): 1007S–1015S.

Cameron Rink et al., “Oxygen-Inducible Glutamate Oxaloacetate Transaminase as Protective Switch Transforming Neurotoxic Glutamate to Metabolic Fuel during Acute Ischemic Stroke,” Antioxidants and Redox Signaling 14, no. 10 (May 15, 2011): 1777–1785, DOI: 10.1089/ars.2011.3930.

Francisco Campos et al., “Blood Levels of Glutamate Oxaloacetate Transaminase Are More Strongly Associated with Good Outcome in Acute Ischaemic Stroke Than Glutamate Pyruvate Transaminase Levels,” Clinical Science 121, no. 1 (July 2011): 11–17, DOI: 10.1042/CS20100427.

M. Yudkoff et al., “Brain Amino Acid Metabolism and Ketosis,” Journal of Neuroscience Research 66, no. 2 (October 15, 2001): 272–281, DOI: 10.1002/jnr.1221John P. M. Wood and Neville N. Osborne, “Zinc and Energy Requirements in Induction of Oxidative Stress to Retinal Pigmented Epithelial Cells,” Neurochemical Research 28, no. 10 (October 2003): 1525–1533.

J. D. Johnson, D. J. Creighton, and M. R. Lambert, “Stereochemistry and Function of Oxaloacetate Keto-Enol Tautomerase,” Journal of Biological Chemistry 261, no. 10 (April 5, 1986): 4535–4541.

Montserrat Marí et al., “Mitochondrial Glutathione, a Key Survival Antioxidant,” Antioxidants and Redox Signaling 11, no. 11 (November 2009): 2685–2700, DOI: 10.1089/ARS.2009.2695.

K. A. Bauerly et al., “Pyrroloquinoline Quinone Nutritional Status Alters Lysine Metabolism and Modulates Mitochondrial DNA Content in the Mouse and Rat,” Biochimica et Biophysica Acta 1760, no. 11 (November 2006): 1741–1748, DOI: 10.1016/j.bbagen.2006.07.009.

Calliandra B. Harris et al., “Dietary Pyrroloquinoline Quinone (PQQ) Alters Indicators of Inflammation and Mitochondrial-Related Metabolism in Human Subjects,” Journal of Nutritional Biochemistry 24, no. 12 (December 2013): 2076–2084, DOI: 10.1016/j.jnutbio.2013.07.008.

Kathryn Bauerly et al., “Altering Pyrroloquinoline Quinone Nutritional Status Modulates Mitochondrial, Lipid, and Energy Metabolism in Rats,” PLOS ONE 6, no. 7 (July 21, 2011), DOI: 10.1371/journal.pone.0021779.

Kei Ohwada et al., “Pyrroloquinoline Quinone (PQQ) Prevents Cognitive Deficit Caused by Oxidative Stress in Rats,” Journal of Clinical Biochemistry and Nutrition 42, no. 1 (January 2008): 29–34, DOI: 10.3164/jcbn.2008005.

M. Costanzo et al., “Low Ozone Concentrations Stimulate Cytoskeletal Organization, Mitochondrial Activity and Nuclear Transcription,” European Journal of Histochemistry 59, no. 2 (April 21, 2015), DOI: 10.4081/ejh.2015.2515.

Oliver Tucha and Klaus W. Lange, “Effects of Nicotine Chewing Gum on a Real-Life Motor Task: A Kinematic Analysis of Handwriting Movements in Smokers and Non-Smokers,” Psychopharmacology 173, no. 1–2 (April 2004): 49–56, DOI: 10.1007/s00213-003-1690-9.

R. J. West and M. J. Jarvis, “Effects of Nicotine on Finger Tapping Rate in Non-Smokers,” Pharmacology, Biochemistry, and Behavior 25, no. 4 (October 1986): 727–731.

G. Mancuso et al., “Effects of Nicotine Administered via a Transdermal Delivery System on Vigilance: A Repeated Measure Study,” Psychopharmacology 142, no. 1 (n.d.): 18–23, DOI: 10.1007/s002130050857.

A. C. Parrott and G. Winder, “Nicotine Chewing Gum (2 Mg, 4 Mg) and Cigarette Smoking: Comparative Effects upon Vigilance and Heart Rate,” Psychopharmacology 97, no. 2 (1989): 257–261.

S. Phillips and P. Fox, “An Investigation into the Effects of Nicotine Gum on Short-Term Memory,” Psychopharmacology 140, no. 4 (December 1998): 429–433; F. Joseph McClernon, David G. Gilbert, and Robert Radtke, “Effects of Transdermal Nicotine on Lateralized Identification and Memory Interference,” Human Psychopharmacology 18, no. 5 (July 2003): 339–343, DOI: 10.1002/hup.488.; D. V. Poltavski and T. Petros, “Effects of Transdermal Nicotine on Prose Memory and Attention in Smokers and Nonsmokers,” Physiology and Behavior 83, no. 5 (January 17, 2005): 833–843, DOI: 10.1016/j.physbeh.2004.10.005.

Maryka Quik et al., “Chronic Oral Nicotine Normalizes Dopamine Function and Synaptic Plasticity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Primates,” Journal of Neuroscience 26, no. 17 (April 26, 2006): 4681–4689, DOI: 10.1523/JNEUROSCI.0215-06.2006.

David Nutt et al., “Development of a Rational Scale to Assess the Harm of Drugs of Potential Misuse,” Lancet 369, no. 9566 (March 2007): 1047–1053, DOI: 10.1016/S0140-6736(07)60464-4.

William K. K. Wu and Chi Hin Cho, “The Pharmacological Actions of Nicotine on the Gastrointestinal Tract,” Journal of Pharmacological Sciences 94, no. 4 (April 2004): 348–358.

Rebecca Davis et al., “Nicotine Promotes Tumor Growth and Metastasis in Mouse Models of Lung Cancer,” PLOS ONE 4, no. 10 (October 20, 2009), DOI: 10.1371/journal.pone.0007524.

Hani Atamna et al., “Methylene Blue Delays Cellular Senescence and Enhances Key Mitochondrial Biochemical Pathways,” FASEB Journal 22, no. 3 (March 2008): 703–712, DOI: 10.1096/fj.07-9610com.

David J Bonda et al., “Novel Therapeutics for Alzheimer’s Disease: An Update,” Current Opinion in Drug Discovery and Development 13, no. 2 (March 2010): 235–246.

Narriman Lee Callaway et al., “Methylene Blue Improves Brain Oxidative Metabolism and Memory Retention in Rats,” Pharmacology, Biochemistry, and Behavior 77, no. 1 (January 2004): 175–181.

Pavel Rodriguez et al., “Multimodal Randomized Functional MR Imaging of the Effects of Methylene Blue in the Human Brain,” Radiology 281, no. 2 (June 28, 2016): 516–526, DOI: 10.1148/radiol.2016152893.